MERCOSUR: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in MERCOSUR

The MERCOSUR prophylactic medicaments containing insulin market contracted slightly to $X in 2022, with a decrease of X% against the previous year. Over the period under review, consumption showed a mild curtailment. The growth pace was the most rapid in 2021 with an increase of X%. Over the period under review, the market hit record highs at $X in 2013; however, from 2014 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in MERCOSUR

In value terms, prophylactic medicaments containing insulin production reduced to $X in 2022 estimated in export price. In general, production showed a noticeable decline. The most prominent rate of growth was recorded in 2021 with an increase of X%. The level of production peaked at $X in 2012; however, from 2013 to 2022, production stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in MERCOSUR

Prophylactic medicaments containing insulin exports skyrocketed to X tons in 2022, picking up by X% against the previous year. Overall, exports, however, continue to indicate a abrupt curtailment. The growth pace was the most rapid in 2013 when exports increased by X%. The volume of export peaked at X tons in 2014; however, from 2015 to 2022, the exports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin exports soared to $X in 2022. In general, exports, however, showed a abrupt decline. The level of export peaked at $X in 2013; however, from 2014 to 2022, the exports failed to regain momentum.

Exports by Country

The biggest shipments were from Brazil (X tons), together amounting to X% of total export.

Brazil was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics in measured doses exports, with a CAGR of X% from 2012 to 2022. The shares of the largest exporters remained relatively stable throughout the analyzed period.

In value terms, Brazil ($X) also remains the largest prophylactic medicaments containing insulin supplier in MERCOSUR.

From 2012 to 2022, the average annual growth rate of value in Brazil totaled X%.

Export Prices by Country

In 2022, the export price in MERCOSUR amounted to $X per ton, jumping by X% against the previous year. Over the period under review, the export price, however, showed a abrupt downturn. The level of export peaked at $X per ton in 2012; however, from 2013 to 2022, the export prices stood at a somewhat lower figure.

As there is only one major export destination, the average price level is determined by prices for Brazil.

From 2012 to 2022, the rate of growth in terms of prices for Brazil amounted to X% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in MERCOSUR

In 2022, imports of medicaments containing insulin but not antibiotics in measured doses in MERCOSUR dropped to X tons, which is down by X% on 2021. Total imports indicated a prominent increase from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by X% against 2013 indices. The most prominent rate of growth was recorded in 2014 when imports increased by X%. Over the period under review, imports reached the maximum at X tons in 2021, and then declined in the following year.

In value terms, prophylactic medicaments containing insulin imports expanded sharply to $X in 2022. Overall, imports, however, showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2014 when imports increased by X%. As a result, imports attained the peak of $X. From 2015 to 2022, the growth of imports remained at a somewhat lower figure.

Imports by Country

In 2022, Colombia (X tons), distantly followed by Brazil (X tons), Chile (X tons) and Argentina (X tons) were the largest importers of medicaments containing insulin but not antibiotics in measured doses, together making up X% of total imports. Ecuador (X tons), Peru (X tons) and Paraguay (X tons) held a relatively small share of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the key importing countries, was attained by Colombia (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin importing markets in MERCOSUR were Colombia ($X), Chile ($X) and Brazil ($X), with a combined X% share of total imports. Argentina, Peru, Paraguay and Ecuador lagged somewhat behind, together accounting for a further X%.

Among the main importing countries, Paraguay, with a CAGR of X%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in MERCOSUR stood at $X per ton in 2022, surging by X% against the previous year. Over the period under review, the import price, however, showed a perceptible descent. The level of import peaked at $X per ton in 2013; however, from 2014 to 2022, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Paraguay ($X per ton), while Brazil ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Paraguay (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :